At Celvivo, we’re on a mission to help scientists push the frontiers of 3D cell culture. Our Clinostat-based technology enables cells in vitro to recover lost physiological attributes, re‑establish intercellular communication, and perform more like they do in vivo - Whether you work with spheroids or organoids. We designed the Celvivo Clinostar and ClinoReactor on four core principles: 3D cell culture should be relevant, abundant, easy‑to‑use, and reproducible. In close collaboration with researchers worldwide, we’re solving long‑standing challenges like active diffusion bias and shear stress, so your models can be more predictive and more meaningful. Friendly, nerdy, premium, and pioneering - that’s who we are. And with the most user‑friendly system for organoids yet, we invite you to join us in shaping the future of 3D cell culture based research. Celvivo Refine your research
Looking for a particular CelVivo employee's phone or email?
The CelVivo annual revenue was $4 million in 2026.
Peter Willems-Alnøe is the CEO of CelVivo.
24 people are employed at CelVivo.
CelVivo is based in Blommenslyst, South Denmark.
The NAICS codes for CelVivo are [5417, 541, 54171, 541713, 54].
The SIC codes for CelVivo are [87, 873].